Correlation Between Genetic Technologies and Medical Developments

Can any of the company-specific risk be diversified away by investing in both Genetic Technologies and Medical Developments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genetic Technologies and Medical Developments into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genetic Technologies and Medical Developments International, you can compare the effects of market volatilities on Genetic Technologies and Medical Developments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genetic Technologies with a short position of Medical Developments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genetic Technologies and Medical Developments.

Diversification Opportunities for Genetic Technologies and Medical Developments

0.0

Correlation Coefficient

Genetic Technologies  Medical Developments

Pay attention - limited upside

The 3 months correlation between Genetic and Medical is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Genetic Technologies and Medical Developments Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medical Developments and Genetic Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genetic Technologies are associated (or correlated) with Medical Developments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medical Developments has no effect on the direction of Genetic Technologies i.e., Genetic Technologies and Medical Developments go up and down completely randomly.

Pair Corralation between Genetic Technologies and Medical Developments

If you would invest  41.00  in Medical Developments International on December 30, 2024 and sell it today you would earn a total of  13.00  from holding Medical Developments International or generate 31.71% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Genetic Technologies  vs.  Medical Developments Internati

Genetic Technologies

Risk-Adjusted Performance

Very Weak

Over the last 90 days Genetic Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Genetic Technologies is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Medical Developments

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Medical Developments International are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Medical Developments unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Genetic Technologies and Medical Developments

The main advantage of trading using opposite Genetic Technologies and Medical Developments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genetic Technologies position performs unexpectedly, Medical Developments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medical Developments will offset losses from the drop in Medical Developments' long position.

The idea behind Genetic Technologies and Medical Developments International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.